Dianthus Therapeutics
DNTH
DNTH
72 hedge funds and large institutions have $174M invested in Dianthus Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
-2
Holders Change %
-2.7%
% of All Funds
1.59%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
9
Increased
25
Reduced
19
Closed
11
Calls
$1K
Puts
$1K
Net Calls
–
Net Calls Change
-$1K
Top Buyers
| 1 |
BL
Bleichroeder LP
New York
|
+$1.58M |
| 2 |
Renaissance Technologies
New York
|
+$1.07M |
| 3 |
Millennium Management
New York
|
+$692K |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$332K |
| 5 |
Truist Financial
Charlotte,
North Carolina
|
+$296K |
Top Sellers
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$10.1M |
| 2 |
CC
Casdin Capital
New York
|
-$798K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$459K |
| 4 |
MA
MYDA Advisors
Woodmere,
New York
|
-$334K |
| 5 |
VFA
Values First Advisors
Gray,
Tennessee
|
-$331K |
